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Background: The aim of the present study was to develop a haemolytic assay for the study of the complement
system in dairy goats (Capra aegagrus hircus) and to characterize the major goat complement system proteins.
Results: The commonly used sheep erythrocyte sensitized with rabbit antibodies were not sensitive to lysis by goat
serum, but the combination of human red blood cells (RBC) plus rabbit antibodies was the best option found for
goat complement assay. A buffer based on HEPES instead of the classical veronal (barbitone) was developed.
Three proteins were isolated: factor H, C1q and C3 and these were compared with the corresponding human
proteins. A novel affinity chromatography technique was developed for isolation of factor H.
Conclusions: Human RBC plus rabbit antibodies were a suitable option for haemolytic assays. The isolated proteins
are similar to the human counterparts.
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Complement is a central component of the innate
immune system which is involved in host defense against
infectious agents [1]. It has three physiological activities:
defending against pyogenic bacterial infection, bridging
innate and adaptive immunity, and disposing of immune
complexes and the products of inflammatory injury [2].
The complement system may be activated by three dif-
ferent pathways: the classical, the lectin and the alterna-
tive pathway [3]. The classical pathway is activated by
binding of the C1q protein to targets, such as Gram
negative bacteria, immunoglobulins bound to microor-
ganisms or altered host components, such as amyloids
or apoptotic cells; the alternative pathway may be dir-
ectly activated by microorganisms and also by IgG
immune complexes. The lectin pathway is activated by
MBL (mannose-binding lectin) bound to carbohydrates
present on the surface of microbes [4]. The lectin path-
way of complement can also be activated via L-ficolin
[5], H-ficolin [6], M-ficolin [7] and by the recently-
described Collectin 11 [8]. The complement system in
mammals has been well described, particularly in human* Correspondence: aarguello@dpat.ulpgc.es
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distribution, and reproduction in any mediumand mice. Some other vertebrate species have been
examined at various levels of detail (e.g. chimpanzee,
dog, horse, sheep, guinea-pig, pig, cattle, chicken and
some fish), and it is clear their complement systems are
very similar [1]. In vertebrate studied, the complement
system consists of about 35–40 proteins commonly asso-
ciated with blood plasma and blood cells, but found
generally at lower concentration in other secretions of
the body [9], like lymph, colostrum or milk [3].
In farm animals, the complement system has been
studied principally in cows [10-12], although there are
some studies in other ruminants, like buffalos [9]. There
is scanty research papers on goats.
Some studies on conditions for assaying haemolytic
complement of goat sera [13] and in particular of the
alternative complement pathway [14] have been pub-
lished. Other published work on goat complement
includes studies of infection with some parasites like
Trypanosoma evansi [15] or with the estimation of the
molecular size of the C1 complex [16], purification of
C1q [17] or mapping of MHC-linked complement genes
[18]. In theses studies, C2 and C4 were found to be
MHC-linked, as in humans.
Recently, Castro et al. [19] demonstrated a relation-
ship between nutrition and complement system activity
in goat kids during the first two months of life. MoreCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 2 Comparison of HEPES (DGHB++) and Veronal (DGVB++)
buffers. Serial 2-fold dilutions of human serum were prepared in
either buffer, starting at 1/20 (5%). Dilutions (100 μl) were mixed
with 100 μl of 108/ml sheep EA cells, in the same buffer, and
incubated for 1hour, at 37 °C. Percentage lysis was calculated as
in methods.
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cessary to understand this relationship in depth.
The aim of the present study was to develop an effi-
cient combination of antibodies and RBC to provide a
feasible haemolytic assay for goat serum/plasma. An
additional objective was to isolate the major complement
system proteins from goat plasma, in order to raise anti-
bodies for future quantitative concentration measure-
ments. The proteins were C1q, the first protein involved
in the classical pathway [20], factor H, because of its
importance in the regulation of the alternative pathway
[21], and C3, the most abundant protein (at least in
humans) which forms part of all three pathways [22].
Results
Figure 1 shows the tests results of goat, human and
guinea pig serum/plasma against various RBC prepara-
tions. Goat plasma and serum showed completely differ-
ent specificity from human and guinea pig serum. Goat
plasma and serum lysed human RBC sensitized with
rabbit antibodies, but human and guinea pig serum had
no activity against these cells. There was also some lysis
of unsensitised human erythrocytes by goat serum and
plasma. In contrast, goat serum/plasma did not lyse
sheep erythrocytes with any combination of antibodies
(even with goat antibodies), while human and guinea pig
sera did lyse these cells. Lysis of unsensitised sheep ery-
throcytes by human serum is due to the presence of
anti-Forssman antibodies in the human serum/plasma.
It was necessary to adapt the assay to a more suitable
buffer, because of the difficulty in obtaining sodium bar-
bital (veronal) in some countries. HEPES was tried
instead of barbitone. Figure 2 shows the comparison ofFigure 1 Lysis of different cells, with and without antibody by
human, goat and guinea-pig plasma/serum (HCP and HS, GCP
and GS, and GPS, respectively). Sheep (sE) and human (hE)
erythrocytes were pre-coated or not with rabbit or rabbit + goat
antibodies. Erythrocytes (50 μl of 109/ml) in DGVB++ were incubated
with 100 μl of 1/5 dilution of plasma/serum for 1 hour at 37 °C.
Percentage of cell lysis was calculated as indicated in methods
section.sE, hE: sheep and human erythrocytes without pre-coated;
sEA, hEA= sheep and human pre-coated with rabbit antibodies; RA,
GA, HA= rabbit, goat and human antibodies, respectively.the two buffers for an assay of human serum comple-
ment with sheep EA. Although both buffers work simi-
larly, the titre measured was slightly higher with HEPES.
Further experiences in using both buffers for goat com-
plement showed that both are suitable for assays, but
whereas DGVB++ is a good buffer for long-term storage
of RBC, DGHB++ needs to be removed and changed for
another buffer to store the EA cells. A good buffer to
store the cells is Alsever’s Solution.
The effects of “classical” versus “alternative” pathway
buffers on goat complement assay are shown in figure 3.Figure 3 Titration of sensitising antibody and effects of
“classical pathway” versus “alternative pathway” condition.
Human RBC (E) were used without sensitization or sensitised with
10 μl anti(human RBC) antiserum per ml of 109 cells/ml (EA1) or with
100 μl antiserum per ml of 109 cells/ml (EA2). Two-fold serial dilutions
of goat serum were made in either DGHB++ or DGHB-Mg-EGTA,
starting at 1:1 (50%). Dilutions (100 μl) were incubated with E, EA1
or EA2 cells (100 μl of 108/ml) in the same buffer for 1hour at 37 °C.
Percentage lysis was calculated, and the serum concentration
(% serum) required for 50% lysis calculated. CH50 (the number of
complement lysis units in 100% serum).
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pathways can be activated, although it would be expected
that the classical pathway works at lower serum concen-
trations than the other pathways. In DGVB-Mg-EGTA
or DGHB-Mg-EGTA only the alternative pathway can
work, because the other pathways require Ca2+ (for the
binding of the proteases C1r, C1s or the MASPS, to C1q,
MBL or ficolins). Two different sensitising antibody con-
centrations are shown. When the assay was done with
hE cells, goat serum showed a titre of about 5 CH50
units in either buffer. A two-fold higher titre was
obtained when the EA cells were sensitised with a low
concentration of rabbit anti(human RBC) (about 80–
100 CH50 units in either buffer); however, at higher anti-
body concentration a higher titre was observed and in
the alternative pathway buffer this titre was more pro-
nounced than in the classical pathway buffer (350 CH50
units versus 150 units). In a separate experiment, the
concentration of antibody was varied titrating the anti-
human RBC, and the maximum titre response was
obtained with concentrations higher than 80 μl of anti-
serum per ml of cells at 109/ml in DGHB++ (not shown).
The fact that the titre in the alternative pathway was
higher than in the classical pathway, suggests that ele-
vated concentration of antibody present on the cells
seems to activate the alternative pathway. As it has been
shown by Gadd and Reid [23] antigen-bound rabbit IgG
activates the alternative pathway (in human serum). The
antiserum used (rabbit anti-human RBC membrane) was
produced with booster injections of antigen over a
6 months period, so it had mainly an IgG response. The
CH50 values for various serum samples from different
goats are shown in figure 4. These results demonstratedFigure 4 Comparison of multiple samples. Ten goat serum
samples were assayed (as described in the legend for fig. 3) using
DGHB++ and DGHB-Mg-EGTA buffers, and highly sensitised EA
(equivalent to EA2 in fig. 3). The titre of each sample CH50 units in
the assay is shown for both buffer conditions.that this assay (using the maximum antibody sensitisa-
tion) is able to distinguish among different samples. The
fact that the alternative pathway buffer, in all cases gave
higher values than the classical pathway buffer is very
interesting, and it must be studied in greater detail.
A possible explanation could be the fact that the magne-
sium ion concentration affects the apparent titre in alter-
native pathway assays [24].
SDS-PAGE analysis of factor H (FH) purification is
depicted in figure 5. Factor H was identified by its
chromatographic behaviour and co-running with human
FH on SDS-PAGE; FH forms the major symmetrical
peak on the final gel filtration step. As previously
observed [25], human factor H binds strongly to TNP-
derivatised BSA. As shown here, goat factor H also
binds to TNP. This binding is of high affinity, so that
high salt/denaturing buffers are required for elution of
the bound protein. Factor H, however, is resistant to
denaturation, and use of urea/guanidine buffers would
not be expected to cause loss of activity.
SDS-PAGE with various fractions of goat C1q from
the final mono-S ion exchange is shown in figure 6. The
yield from purification was low, but purity was adequate.
Human IgG was used as the affinity ligand, and the
result confirms that goat C1q does bind to human IgG,
although SRBC sensitised by human IgG/IgM are not
lysed by goat serum/plasma (fig 1). The Goat C1q
appears similar to human C1q on SDS-PAGE. With C1qFigure 5 Isolation of Goat Factor H. a) Gel flitration of goat FH on
Superose 6. b) SDS-PAGE analysis of reduced goat FH fractions.
lane 1: Molecular weight standard, lane 2: human Factor H, lane 3:
Factor H before the gel filtration, lane 4: fraction 12 from the gel
filtration, lane 5: fraction 13 from the gel filtration. Gel was stained
with Coomassie blue.
Figure 6 Purification of goat C1q. a) Ion Exchange (monoS)
chromatogram of C1q. b) SDS-PAGE analysis of reduced goat C1q
fractions. Lane 1: Molecular weight standard, lane 2: human C1q,
(with a contaminant ~50 kDa), lane 3: fraction 16 from the ion
exchange, lane 4: fraction 22, lane 5: fraction 24. Fractions were
concentrated with Strataclean beads. Gel was stained with
Coomassie blue.
Figure 7 Isolation of C3. a) Gel filtration of goat C3 on Superose 6.
b) SDS-PAGE of the final step gel filtration on Superose 6. Lane 1:
Molecular weight standard, lane 2 and 3: fractions of the gel
filtration (14, 15). Fractions were concentrated with Strataclean
beads. Gel was stained with Coomassie blue.
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the a, b and c chains may differ. In human, a doublet
band at ~ 29 kDa represents the a and b chains, while a
fainter band at ~ 25kda is the c chain. The c chain aggre-
gates in SDS-PAGE, and may also appear as faint higher
bands (50–70 kDa). For goat C1q, there is a fainter band
at ~ 29kda, which may represent the c chain, and a
strong band at ~25 kDa, which most likely represents
the co-running a and b chains. C1q is a basic high
molecular weight glycoprotein which has two major
problems in its purification: a low yield and contaminant
inmunoglobulins [26], and because of its low yield, it
was necessary to concentrate samples for SDS-PAGE
analysis with Strataclean beads (Stratagene).
SDS-PAGE analysis of fractions of the last gel filtration
of the purification of C3 is shown in figure 7. Goat C3
was of good purity although it could be contaminated
with C5. C3 and C5 are homologues of the same mol.
wt., and in human and rodent, they tend to co-run in
chromatographic procedures [27]. The minor band
under the C3 alpha chain, marked C3 alpha’, may repre-
sent either the alpha’ chain of C3b, or the alpha chain
of C5.
Discussion
Sheep erythrocytes do not work in the assay of comple-
ment in Majorera goat samples in agreement with the
results of Venugopal et al. [14], who found negligible
activity using sheep and cattle erythrocytes, working
with goats of undefined breed. This was not observedpreviously by Olaho-Mukani et al. [15] who used sheep
RBC with good results with African goats. Oyekan and
Barta [13] showed that the best results for goat comple-
ment (breed not stated) were obtained with guinea
pig or pig erythrocytes sensitized with goat or cattle
antibodies, They also observed lysis with unsensitised
rabbit and horse erythrocytes, and low but detectable
lysis with sensitised sheep erythrocytes. Noguchi and
Bronfenbrenner [28] did observe that human RBC were
usable for testing goat complement. Castro and co-workers
[19] used also Majorera goats for their experiment with
rabbit erythrocytes without sensitizing.
The resistance to lysis of sheep RBC may be because
sheep complement regulatory proteins (equivalent to
CD59 or DAF) are compatible with goat complement
proteins. These types of protein protect host cells from
autologous complement attack [29]. These results could
be due to a structural similarity between the interac-
tion sites of proteins of both species. For a long time,
bovine complement was considered to be nonhemolytic,
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However, in Holstein Bull serum, Chang–Fa et al. [31]
did not find any relationship between phylogenetic prox-
imity of erythrocyte species to cattle and the degree of
hemolysis, attributing this response to the content of the
serum of high levels of natural antibodies against RBC
of various species. The highest was against guinea pigs
and the lowest against cows, sheep, goats and pigs. So, it
is possible that in goats something similar happens.
In general, as expected the sensitivity of the assay was
improved by sensitization of the erythrocytes with
specific antibodies, which enhances the activation of the
classical pathway (IgG and IgM) and the alternative
pathway (IgG). Buffer was changed because it is diffi-
cult to get veronal buffer in some laboratories. Veronal
(sodium barbiturate) is the most widely reagent used
to measure the activity of the complement system
[4,13-15,32], but other buffers have been used to measure
the activity. For example Castro et al. [19] used PBS and
saline to measure the total complement system activity
in kid goat serum although to measure the alternative
pathway it was necessary to use the normal EGTA-Mg-
gelatin-Veronal buffer. HEPES is a good buffering agent
for maintaining physiological pH. The major problem
was the storage of RBC in this buffer, which was much
poorer than in DGVB++. For this reason is better to use
another buffer, such as Alsever’s solution for storage, to
wash the erythrocytes frequently and to minimize as
much as possible the storage period in HEPES. The high
values for titres in the alternative pathway buffer were
unexpected. The “classical pathway” buffer allows activa-
tion of all three pathways, while the “alternative pathway”
buffer allows only the alternative pathway to work.
It was expected a lower titre for the alternative path-
way as the classical pathway usually dominates the activ-
ity of the complement system in most species, e.g.
classical pathway activity is detectable in more dilute
serum than is lectin or alternative pathway activity [4].
The same titre value in the two buffer systems would
suggest that the activity of the complement system is
due to the alternative pathway, but in our work a higher
value was observed in the alternative pathway buffer.
These results are consistent with previous findings
showing that goats have potent alternative pathway acti-
vation as was suggested by Venugopal et al. [14], and
supported by Castro et al. [19] and Rodríguez et al. [33]
who, working with Majorera goat kids, found that the
only pathway used was the alternative. The alternative
pathway is continually activated at a low controlled rate
but amplified by the surface of invading microorganisms
[34]. The environment where the goats live is controlled,
e.g., nutrition, hygiene or health are supervised by the
University staff, and it is thought that microbes that acti-
vate the alternative pathway are less pathogenic thanthose which do not [35], so that mutation causing loss
of the classical pathway (e.g. loss of C4) might not be a
survival factor for these goats.
The higher titre found in the alternative pathway
buffer could be due to the higher Mg2+ concentration;
Fishelson and Müller-Eberhard [24], showed that raising
the Mg2+ concentration increased the alternative path-
way titre. It would be interesting to probe with different
of Mg2+concentrations, Venugopal et al. [14] found that
higher levels of Mg2+ ions (>5 mM) had an inhibitory
effect on the caprine alternative pathway. Matheswaran
et al. [9], working with buffalo colostrum and with con-
centrations from 4 to 20 mM of Mg2+, found no differ-
ences, although they chose the concentration of 4 mM
as optimum.
The apparent absence of classical pathway could be
due to a failure in some component of the classical path-
way cascade, possibly a C4 deficiency, or perhaps just
because some components were in low concentration,
as it occurs in bovine milk with C1q [36].
Factor H controls the activity of the alternative pathway
C3/C5 convertase by competing with factor B for C3b
binding and by serving as a cofactor for factor I, to mediate
the cleavage of C3b to iC3b [29]. Many procedures have
been used to purify factor H. In humans, Sim and Discipio
[21] used five chromatography steps to isolate Factor H:
first two steps of polyethyleneglycol (PEG) precipitation
were used, continuing with L-Lysine- Sepharose 4B
chromatography, DEAE-Sephadex A-50 chromatography,
Sepharose 6B gel filtration, Hydroxyl-Apatite-Ultrogel
chromatography and finally a DEAE-Sepharose CL-6B
chromatography. Nakano et al. [37] used a shorter
procedure to isolate rabbit factor H using various
precipitation steps with PEG then three steps of
chromatography on DEAE Sephacel; and a further two
steps of Sephadex G200 gel filtration. Mhatre and Aston
[38] used a first step of PEG precipitation then three
steps of chromatography: DEAE-Sephacel, CM-Sephadex
A-50 and Sephadex G-200 to isolate bovine Factor H.
More recently, Factor H has been isolated from porcine
seminal plasma by using a Q-Sepharose column then a
Matrex Gel Red A column, finishing with an FPLC
Superdex 200 column [39]. The method used in the
present study seems to be easier and faster and with
good results as shown in figure 5. It has three steps:
TNP-BSA- Sepharose, protein G Hi-Trap and Superose
6. Binding of human factorH to TNP-BSA had been
observed before [24], but this is the first report where
this ligand for affinity purification is used.
C1q has a critical function in host defence and clear-
ance of immune complexes, and for this reason it is
desirable to study goat C1q in more depth. Lin et al.
[17] used 2 different methods for the purification of goat
C1q: in one, the procedure was based on two successive
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an additional purification through a Sepharose CL-6B
gel filtration column; and in the other, they used a two-
step chromatography, with a BioRex 70 and a Sepharose
CL-6B columns. C1q is a protein which has a high affin-
ity for heparin and IgG, so McKay [40] used these char-
acteristics to make a two-step affinity chromatography
procedure to purify C1q from various species (human,
rat, rabbit, dog and sheep). Pohl et al. [41] isolated C1q
using a three-step purification procedure: precipitation
from plasma, affinity chromatography with a rabbit IgG-
Sepharose column and cleaning up with a rabbit anti-
human IgG-Sepharose affinity column. Sasaki et al. [42]
working with guinea pig serum, combined precipitation
with chelating agents, CM-cellulose and Superose 6, and
Stemmer and Loos [43] used a simple and rapid proced-
ure for the purification of C1q from human, guinea pig
and mouse serum, with euglobulin precipitation, chro-
matography on Superose 6B, then Mono S ion exchange.
To establish a simple method to isolate goat comple-
ment C1q, previous reports were used as references. As
several procedures used immobilised IgG, non-immune
human IgG-Sepharose was chosen to begin, followed by
a Protein G Hi-trap column to remove contaminant
human IgG, ending with ion exchange chromatography
on MonoQ and MonoS to remove all the contaminants.
The yield was very low, possibly because the concentra-
tion of this protein in goats is low, or because human
IgG may not be a very high affinity ligand. As noted
above, it is possible that C1q is present in low concen-
tration, in that there was very low apparent classical
pathway complement activation.
Although little is known about the goat complement
genome, only goat C9 and Factor B have been sequenced
as far as we know, a goat genome project is in progress
[44] and probably in the next years the sequences of the
complement system proteins will be known, so that we
will be able to compare the sequences with humans or
other species and learn about potential structural or
functional differences.
Complement C3 may be the most studied protein of
the complement system, due to its abundance and
importance in all three pathways. It has been studied
and isolated from many species and usually C3 has been
isolated in a similar way with a first step of differential
precipitation with PEG, continuing with column chroma-
tography (e.g. Giclas et al. [45] for rabbit and Gresham
et al. [46] for human). Storm et al. [47] isolated porcine
C3 with PEG precipitation and DEAE-Sephacel chroma-
tography, ending with a size exclusion chromatography
with Sepharose CL-6B and a hydroxylapatite chromatog-
raphy to remove the contaminants. Basta and Hammer
[48], established a two step protocol to isolate C3: PEG
precipitation and fast protein liquid chromatography(FPLC) Mono Q ion exchange chromatography, using
human and guinea pig. A procedure used in fishes like
the spotted wolfish, in which a PEG precipitation, contin-
ued by a MonoQ and a Superose 12 exclusion chroma-
tography was described by Abelseth et al., [49]. Most
recent procedures for the isolation of this protein have
been based on the work of Dodds [50] which was used in
the present study and consists of PEG precipitation, and
2–3 ion-exchange steps.
There has been no report of C3 isolation from goats,
but in other ruminants, C3 has been purified from cows
[51] using a four step protocol: polyethylene glycol pre-
cipitation and chromatography on DEAE-Sephadex A-50,
CM-Sephadex A-50 and Sephacryl S-200. In camels, the
same procedure was followed by Ouma et al. [52]. In the
present study the protocol has been simplified to three
steps based on a Q Sepharose FF, followed by a MonoQ
and a Superose 6.
Conclusions
The alternative pathway of the goat complement system
is the predominant pathway. Human RBC plus rabbit
antibodies are the best option for haemolytic assays.
HEPES buffer is a good alternative for laboratories
where Veronal buffer is difficult to acquire. The main
proteins Factor H, C1q and C3 in goats were isolated
and are similar to the human counterparts.
Materials and methods
This study was performed in accordance with adequate
ethical standards and animal care and was approved by the
Ethics and Animal Welfare Committee of the University of
Las Palmas de Gran Canaria, Las Palmas, Spain.
Plasma/serum
Blood samples from Majorera goats were obtained at
Las Palmas de Gran Canaria University (Animal Science
Department). Health status of the animals was suitable.
Animals were vaccinated against Staphylococcus aureus
and their feeding regime was based on corn, soy 66,
dehydrated lucerne, dehydrated beetroot, wheat straw
and a vitamin–mineral corrector, in accordance with the
guidelines issued by L’Institut de Recherche Agrono-
mique [53].
Blood was taken from the jugular vein into a tube with
buffered sodium citrate 0.106 M (100 ml of this buffer
to 1 L of blood) and centrifuged for 10 minutes at
2,130 g and 4 °C. Plasma was then frozen at −80 °C and
transported on dry ice to Oxford University where labora-
tory determinations were performed. The initial sample
was citrated-plasma, so it was converted to serum by add-
ing CaCl2 to a final concentration of 20 mM, incubating
for 20 minutes at 37 °C and centrifuging for 15 minutes
at 2,500 g.
Moreno-Indias et al. BMC Veterinary Research 2012, 8:91 Page 7 of 9
http://www.biomedcentral.com/1746-6148/8/91Haemolytic assays
Buffers
Initial haemolytic assays were based on reagents
described by Whaley and North [25]. DGVB++ buffer
(Dextrose Gelatin Veronal Buffer, with Ca++ and Mg++:
2.5 mM sodium barbital, 71 mM NaCl, 0.15 mM CaCl2,
0.5 mM MgCl2, 2.5%(w/v) glucose, 0.1% (w/v) gelatin, pH
7.4) was used for the classical pathway and DGVB-Mg-
EGTA buffer (2.1 mM sodium barbital, 59 mM NaCl,
7.0 mM MgCl2, 2.08%(w/v) glucose, 0.08% (w/v) gelatin,
10 mM EGTA, pH 7.4) for the alternative pathway.
In later analyses the DGVB++ buffer was changed
for DGHB++ buffer in which 5 mM HEPES replaced
2.5 mM sodium barbital and the DGVB-Mg-EGTA was
changed for DGHB-Mg-EGTA, in which 4.2 mM HEPES
replaced 2.1 mM sodium barbital
Preparation of antibody-sensitised erythrocytes (EA)
EA cells were prepared as described by Whaley and
North [25]. Sheep erythrocytes (sE) were from sheep
blood in Alsevers (TCS Biosciences Ltd., Buckingham-
shire, UK) and rabbit antibody was haemolysin (Sigma-
Aldrich, Poole, UK). sE and sEA were prepared as
described by Whaley and North [25]. To prepare sheep
erythrocytes with goat antibodies, (sEA+GA), goat-anti-
rabbit IgG antibodies were added to sEA. sEA (0.5 ml at
109/ml) were incubated with 0.5 ml (1:1000) goat anti-
rabbit IgG (Sigma-Aldrich, Poole, UK) for 1 hour at RT.
After that, two washes in DGVB++ were done. Human
erythrocytes (hE) were prepared from blood collected
from healthy volunteers, taken with EDTA as anticoagu-
lant and rabbit anti-(human RBC membrane) antiserum
was from the MRC Immunochemistry Unit. Blood sam-
ples were centrifuged (10 min, 2500 g) and plasma was
removed and stored for later assays. hE were washed in
PBS- 0.5 mM EDTA and then 2 times in DGHB++ until
the supernatant was clear. Then the concentration of hE
was adjusted to 109/ml as for sE. To prepare hEA cells,
10 ml of hE cells were incubated with 100 μl of rabbit
anti-(human RBC membrane) antiserum heat-treated for
30 minutes at 56 °C. After that, 2 washes in DGHB++
were done and cell number adjusted to 109/ml. sE were
also sensitised with human antibodies (anti-Forssman).
Two ml of sE at a concentration of 109/ml and 1 ml of
human EDTA-plasma were mixed and incubated for
30 min at 37 °C. Then cells were washed with DGVB++
and adjusted again to 109/ml.
Establishing a haemolytic assay for goat serum
Tests were done with different combinations of erythro-
cytes and antibodies to establish what system was most
sensitive to lysis by goat complement. These combina-
tions were: sheep RBC, sheep RBC plus rabbit antibodies
(haemolysin, containing IgM and IgG), sheep RBC plusrabbit haemolysin plus goat IgG anti-rabbit IgG (Sigma),
human RBC, human RBC plus rabbit antihuman red
blood cell membrane (IgM and IgG) and sheep RBC plus
human antibodies (IgM and IgG anti-Forssman). In ini-
tial tests, 50 μl of cells or antibody-sensitized cells at
109/ml was incubated with 100 μL of serum or plasma
diluted to 1/5 in DGVB++ for 1 hr at 37 °C before calcu-
lation of lysis as described below.
Haemolytic titration assay
A typical classical pathway (CH50) test was done using
100 μl of goat serum serial 2-fold dilutions (starting at
50% serum, serially diluting 10 times) in DGVB++, mixed
with 100 μl of 108/ml EA cells in DGVB++. E cells were
also used as controls in place of EA. Cells and sera were
incubated for 1 hr at 37 °C, centrifuged (10 min,
2,500 g) and the OD 405 of the supernatant measured to
assess lysis. Percentage complement-dependent lysis was
calculated relative to cells lysed in water (100% lysis) and
cells incubated with buffer only (0% complement-
dependent lysis). Alternative pathway (AP50) assays were
done in the same way, but with DGVB-Mg-EGTA as
buffer. In later analyses the assay buffers were DGHB++
or DGHB-Mg-EGTA. To calculate CH50 or AP50, %
lysis was plotted against % serum and the serum dilution
giving 50% lysis was determined. The CH50 or AP50
was calculated as 100/(%serum causing 50% lysis) x10
and is expressed as units per ml.
Factor H isolation
For the isolation of factor H a commercial serum (cap-
rine serum, Sera Lab International Ltd) was used. It was
diluted 1:1 with water to reduce ionic strength. For the
isolation of the factor H, 200 ml of the goat serum dilu-
tion was mixed with 20 ml of TNP-BSA-Sepharose, pre-
pared as indicated by Arnold et al. [54], for one hour in
a slow rotary stirrer at 4 °C. The resin was thoroughly
washed with HEPES buffer (10 mM HEPES, 60 mM
NaCl, 0.5 mM EDTA pH 7.4). This affinity column binds
mainly Factor H, IgG and IgM [54]. Three different sol-
vents were assessed for elution of the bound protein:
urea buffer (10 mM MES, 6 M urea pH 6.0); 2 M NaCl;
and 6 M guanidine-HCl buffer (6 M guanidine-HCl,
10 mM Tris, 100 mM Na phosphate pH 8.0-8.2). The
resin was placed in a column and washed successively
with the three solvents and fractions of 4 ml were col-
lected. Elution was monitored by reading OD 280.
Fractions containing protein were dialysed against
PBS-0.05 mM EDTA. The best eluants were the 2 M
NaCl and Guanidine buffer, according to the amount of
eluted protein measured at OD280 and analysis by SDS-
PAGE. Fractions eluted in these solvents were pooled to-
gether and passed thought a 1 ml Protein G “Hi-Trap”
column (GE Healthcare) to remove IgG. The column
Moreno-Indias et al. BMC Veterinary Research 2012, 8:91 Page 8 of 9
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eluted with Glycine/HCl buffer (0.2 M glycine adjusted
to pH 2.2 with HCl). To purify Factor H further gel filtra-
tion was used with a Superose 6 10/300 GL column (GE
Healthcare), using filtered PBS-5 mM EDTA as running
buffer. Purification was monitored by SDS-PAGE anal-
ysis using human factor H as standard.
C1q isolation
The diluted goat serum which passed through TNP-
BSA-Sepharose was used to prepare C1q. For the isola-
tion of subcomponent C1q, 25 ml of non-immune
human IgG-Sepharose prepared as indicated by Sim
et al. [55] was added to 200 ml of the diluted goat serum
and incubated for 1 hour close to 0 °C on a slow rotary
stirrer. The IgG-Sepharose was rapidly and thoroughly
washed on a scintered glass filter with ice-cold PBS-
5 mM EDTA and bound proteins were eluted with ice-
cold CAPS buffer (50 mM CAPS, 1 M NaCl, 5 mM
EDTA, pH 11.0 to 11.2). The pH of the eluted fractions
was reduced to 7.5 by adding a buffering substance
(0.5 M NaH2PO4). The eluted protein (without dialysis)
was passed through a Hi-Trap protein G column to
remove IgG. The protein solution was then dialysed
against 10 mM HEPES, 10 mM NaCl pH7.4, and run on
a MonoQ 5/5 column (GE Healthcare) equilibrated in
the same buffer. C1q does not bind to the column,
but contaminants were removed. The run-through frac-
tion containing C1q was finally dialysed against 230 mM
Na-acetate at pH 5.2 and run on a monoS 5/5 column
(GE Healthcare) in the same buffer. C1q was eluted in a
linear gradient of NaCl concentration (0–400 mM NaCl
in the acetate buffer). Purification was monitored by
SDS-PAGE analysis using human C1q as standard.
C3 isolation
For isolation of protein C3, citrated plasma obtained
from a Majorera male goat of the farm of the Las Palmas
de Gran Canaria University was used. C3 was isolated as
described for human C3 by Dodds [50] with minor mod-
ifications. Three chromatography steps were necessary:
an anion exchange chromatography with a Hi Load
16/10 Q Sepharose FF column (GE Healthcare) with the
buffers 20 mM HEPES, 50 mM E-aminocaproic acid,
5 mM EDTA pH 7.4, plus 0.2 mM PMSF, and the same
buffer plus 1 M NaCl; an anion exchange chromatography
with a MonoQ HR 5/5 column with the same buffers; and
finally, a gel filtration chromatography with a Superose
6 10/300 GL column in PBS-5 mM EDTA. Each step was
analyzed with SDS-PAGE (9% (wt/vol) acrylamide).
SDS-PAGE
SDS-PAGE was performed using the method of Laemmli
[56]. Sample buffer, sample preparation and staining withCoomassie Blue were as described by Fairbanks et al. [57].
All samples were run under reducing conditions.
Human C3 and human Factor H, used as standards in
the gels, were purified as described in Dodds [50] and
Sim et al. [55]. Human C1q was prepared as described
by Tan et al. [58]. The molecular weight standard used
was from Sigma.
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